Gut Microbiota Mitigates Chronic Itch and Cutaneous Inflammation in DNFB-Induced Atopic Dermatitis Mice
Authors:
- Zichen XiongZXZichen Xiong
- Xinming DongXDXinming Dong
- Yi YuanYYYi Yuan
- Lin LuLLLin Lu
- Xueting DengXDXueting Deng
Open Access
- 1 February 2026
- journal article
- Published by Taylor & Francis in Journal of Inflammation Research
- Vol. ume 19, 1-17
Abstract
Chronic itch is the most prominent symptom of atopic dermatitis (AD), which severely impacts the quality of life of patients and persists even after medication. Gut microbiota dysbiosis is considered to contribute to AD, however, the roles of gut microbiota in the modulation of chronic pruriceptive processing currently remain unclear. The present study aimed to elucidate the potential regulatory role of the gut microbiota in AD-associated chronic itch. In this study, the 1-fluoro-2,4-dinitrobenzene (DNFB)-induced mouse model of AD-associated chronic itch was established. Differences in gut microbiota composition between model and healthy controls were analyzed using high-throughput 16S rRNA gene sequencing. In addition, we performed oral fecal microbiota transplantation (FMT) from model mice to antibiotic cocktail-treated healthy mice and observed whether they could induce itch behavior. Furthermore, feces from healthy mice were transplanted into model mice to evaluate their effects on itch symptoms and skin inflammation. The DNFB induced significantly itch behaviors and an altered gut microbiota composition. The gut microbiota from chronic itch mice through oral administration could induce itch behaviors in antibiotic cocktail-treated healthy mice. While, oral FMT from healthy mice to chronic itch mice not only significantly alleviated scratching behavior but also ameliorated skin damage and inflammation. Following FMT administration from healthy donors, remarkable alterations were observed in the metabolomic profiles of mice with DNFB-induced chronic itch. These findings highlight the potential link between gut microbiota dysbiosis and chronic itching in AD, suggesting that targeting the gut microbiota may be a therapeutic strategy for chronic itch.Keywords
This publication has 36 references indexed in Scilit:
- Flavonoids from Conyza Canadensis mitigates CDNB-induced mouse model of atopic dermatitisComparative Clinical Pathology, 2025
- Therapeutic effect of bosentan on 2, 4-dinitrochlorobenzene (DNCB)-induced atopic dermatitis mouse modelArchives of Dermatological Research, 2025
- Peripheral itch sensitization in atopic dermatitisAllergology International, 2022
- Alterations in Skin Microbiomes of Patients With CirrhosisClinical Gastroenterology and Hepatology, 2019
- Prevalence of asthma, allergic rhinitis and eczema in 6–7-year-old schoolchildren from Luanda, AngolaAllergologia et Immunopathologia, 2019
- Atopic dermatitis endotypes and implications for targeted therapeuticsJournal of Allergy and Clinical Immunology, 2019
- Patient burden and quality of life in atopic dermatitis in US adultsAnnals of Allergy, Asthma & Immunology, 2018
- Establishment of the intestinal microbiota and its role for atopic dermatitis in early childhoodJournal of Allergy and Clinical Immunology, 2013
- The International Study of Asthma and Allergies in Childhood (ISAAC) Phase Three: A global synthesisAllergologia et Immunopathologia, 2013
- Low diversity of the gut microbiota in infants with atopic eczemaJournal of Allergy and Clinical Immunology, 2012